Latest News & Insights
Stay Up to Date with Our Community
Featured
CAP-003 achieved best-in-class GCase increases in NHPs exceeding levels needed for normalizing activity in patients
CAP-003 achieved best-in-class GCase increases in NHPs exceeding levels needed for...
Warner Biddle Appointed as Chief Executive Officer and to Board of...
In a recent article in Endpoints, Astellas highlights its work in...
Latigo Biotherapeutics Inc. ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid...
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company...
Latigo Biotherapeutics Inc. (“Latigo”), a clinical-stage biotechnology company developing best-in-class non-opioid...
Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class...
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies...
Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on...